von Tobias Borgers | Juni 13, 2022 | Continuous Manufacturing
In the future, Susan Lang believes that 3D printing could be a distributed technology, allowing localised small-batch printing when a medication is needed. XIL Health founder and CEO Susan Lang believes that 3D-printed drugs are poised to be the future of...
von Tobias Borgers | Mai 25, 2022 | Tablet Coating
3D printing has the potential to revolutionise the pharmaceutical manufacturing industry; however, few 3D-printed products have been approved since the first in 2015. In this article, EPR’s Hannah Balfour explores the technologies currently being evaluated for use in...
von Tobias Borgers | Mai 10, 2022 | Continuous Manufacturing, Markt
Thorough supply chain management and end-to-end quality assurance are of utmost value to pharma compliance and patient safety. A significant part of maintaining quality involves ensuring standards are upheld along the global supply chain, regarding active...
von Tobias Borgers | Apr. 12, 2022 | Markt, News
Gerresheimer startet Pharma-Behälterproduktion in Berlin (Ohio) Der Glas- und Verpackungshersteller Gerresheimer hat eine neue Reinraumproduktion in Berlin, im US-Bundesstaat Ohio, eingeweiht. Künftig entstehen dort für den nordamerikanischen Markt...
von Tobias Borgers | Apr. 12, 2022 | Continuous Manufacturing
With the increasing number of biologics, complex oncology therapies, and rare and orphan drugs comprising pharma and biopharma pipelines, manufacturing equipment must provide substantial flexibility. Additionally, the COVID-19 pandemic and vaccine production is...
von Tobias Borgers | Apr. 12, 2022 | Continuous Manufacturing
As pharma and biopharma pipelines trend toward biologics, complex oncology therapies, rare and orphan diseases, and with increasingly stringent FDA requirements, the impact on manufacturing equipment necessitates even greater flexibility. Additionally, the COVID-19...
